4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-026841
EVP, Drug Development gave up 433 shares (to pay taxes)
- EVP, Drug Development acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANHARD KIMBERLY EVP, Drug Development | 2021-04-13 | Option exercise | +1,250 | 2,067 | D | ||
| MANHARD KIMBERLY EVP, Drug Development | 2021-04-13 | Shares withheld for taxes | −433 | $16.66 | $7,214 | 1,634 | D |
| Derivatives | |||||||
| MANHARD KIMBERLY EVP, Drug Development | 2021-04-13 | Option exercise · Restricted Stock Units | −1,250 | 17,500 | D | ||
Loading xslF345X03/doc4.xml…